fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Researchers shorten manufacturing time for CAR T cell therapy

Written by | 1 Apr 2022

A new approach from Penn Medicine researchers could cut the time it takes to alter patients’ immune cells for infusion back into the body to find and attack… read more.

Clinicians report real-world results on the use of a new device to treat brain aneurysms

Written by | 19 Jan 2022

A recent international study led by researchers at Massachusetts General Hospital (MGH) and other institutions offers real-world results on the use of a novel device for treating brain… read more.

Could umbilical cord stem cells cure blood cancer?

Written by | 9 Jan 2022

Stem cells have promised to be the catalyst for major strides in medical research for decades. While progress in some fields has been slower than initially hoped, scientists… read more.

ChemoCentryx announces approval in Japan of Tavneos for the treatment of ANCA-associated vasculitis

Written by | 26 Dec 2021

ChemoCentryx, Inc., announced that Kissei Pharmaceutical Co., Ltd. has received approval from the Japanese Ministry of Health, Labor, and Welfare (MHLW) to market Tavneos™ (avacopan), an orally administered… read more.

Experimental gene therapy reverses sickle cell disease for years

Written by | 24 Dec 2021

A study of an investigational gene therapy for sickle cell disease has found that a single dose restored blood cells to their normal shape and eliminated the most… read more.

Statin use affects prostate cancer screening results

Written by | 10 Dec 2021

Prostate cancer screening results differ in men taking cholesterol-lowering statin drugs compared with non-users, a study conducted at Tampere University in Finland finds. In statin users, screening did… read more.

Aspaveli receives positive CHMP opinion for treatment of paroxysmal nocturnal haemoglobinuria – SOBI + Apellis Pharma

Written by | 9 Dec 2021

Swedish Orphan Biovitrum AB (publ) (Sobi) and Apellis Pharmaceuticals, Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted… read more.

Researchers find warning signs for dementia in the blood

Written by | 24 Oct 2021

Certain microRNAs indicate risk for cognitive decline DZNE – German Center for Neurodegenerative Diseases Researchers at the DZNE and the University Medical Center Göttingen (UMG) have identified molecules… read more.

New discovery explains antihypertensive properties of green and black tea

Written by | 13 Aug 2021

A new study from the University of California, Irvine shows that compounds in both green and black tea relax blood vessels by activating ion channel proteins in the… read more.

New Data for Genentech’s Hemlibra reinforce safety profile in people with hemophilia A

Written by | 1 Aug 2021

Genentech, a member of the Roche Group announced results from the final analysis of the Phase IIIb STASEY study , which confirm the favorable safety profile of Hemlibra… read more.

Impact of blood pressure control programs at barbershops nationwide

Written by | 29 Jun 2021

Hypertension, or high blood pressure, kills more Americans than any other health condition. It is especially prevalent in Black Americans and is exacerbated by structural barriers to accessing… read more.

Cannabis reduces blood pressure in older adults

Written by | 12 Feb 2021

A new discovery by researchers from Ben-Gurion University of the Negev (BGU) and its affiliated Soroka University Medical Center shows that medical cannabis may reduce blood pressure in… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.